Altria develops technology to reduce nicotine in cigarettes – Vaping Post (blog)

A few months ago the FDA announced a new comprehensive plan for tobacco and nicotine regulation, under which the much disputed PreMarket Tobacco Applications (PMTA), was delayed until 2022, and nicotine levels in cigarettes would be reduced.

RNCs may prompt addicts to smoke more in order to obtain the desired level of nicotine, resulting in them inhaling more toxic compounds than they previously did.

“We’ve set out a plan to try to reduce nicotine levels to non addictive or minimally addictive levels to transition people off combustible cigarettes,” said FDA commissioner Scott Gottlieb at the time, whilst pointing out that despite being addictive, nicotine is not the main villain. “It’s not the nicotine that kills you, it’s all the other carcinogens in lighting tobacco on fire,” he said.

Non-surprisingly, following the FDA’s announcement, tobacco stocks took a nosedive and many expected this motion to set off a lobbying fight at the US capitol. “This was a big surprise and will make it imperative that domestic tobacco companies strive to develop innovative, safer products,” said Jack Russo, an analyst with Edward

Read More Here...

This entry was posted in Vaporizer E-Cigarette Stocks News. Bookmark the permalink. Follow any comments here with the RSS feed for this post. Trackbacks are closed, but you can post a comment.